Monoisoamyl meso-2,3-dimercaptosuccinate as a delayed treatment for mercury removal in rats.
Monoisoamyl meso-2,3-dimercaptosuccinate (Mi-ADMS) was found to be superior to meso-2,3-dimercaptosuccinic acid (DMSA) in decreasing the body burden of 203Hg in rats under conditions of early treatment. In this experiment Mi-ADMS was used as late treatment for mercury removal. Albino rats aged 6 wee...
Main Authors: | , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
1994
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1567417/ |